Endogenous repair factor production accelerator

Details Endogenous repair factor production accelerator Endogenous repair factor production accelerator

2003-10-09

2009-06-16

Seaman, D. Margaret (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

07547715

ABSTRACT:
It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) I2 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) I2 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and/or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.

REFERENCES:
patent: 4479966 (1984-10-01), Hayashi et al.
patent: 169725 (1990-03-01), None
patent: 581187 (1996-12-01), None
patent: 860430 (1999-06-01), None
patent: 1121939 (2001-08-01), None
patent: 1175891 (2002-01-01), None
patent: 54-130543 (1979-10-01), None
patent: 2000-86517 (2000-03-01), None
patent: 2000-239188 (2000-09-01), None
patent: 2000-239188 (2000-09-01), None
patent: WO 99/09992 (1999-03-01), None
patent: WO 99/26629 (1999-06-01), None
patent: WO 00/03980 (2000-01-01), None
patent: WO 01/16132 (2001-03-01), None
patent: WO 01/72268 (2001-10-01), None
Hayashi, Jpn. J. Pharmacol, vol. 73, pp. 73-82, 1997.
Yoshitada Saki et al., “Prostaglandin E2 Regulates the Expression of Basic Fibroblast Growth Factor Messenger RNA in Normal Human Fibroblasts,” Kobe J. Med. Sci., vol. 47, No. 35/45, 2001, pp. 35 to 44.
Hiroshi Seno et al., “Cycloocygenase 2-and Prostaglandin E2Receptor EP2-dependent Angiogenesis in Apc716Mouse Intestinal Polyps,” Cancer Research, vol. 62, Jan. 15, 2002, pp. 506-511.
International Search Report dated Dec. 16, 2003.
R. Morishita et al., “Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor”, Diabetologia, vol. 40, pp. 1053-1061, 1997.
M. Majima et al., “Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants”, British Journal of Pharmacology, vol. 130, pp. 641-649, 2000.

Affiliated with

Also associated with

Rating

Endogenous repair factor production accelerator does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endogenous repair factor production accelerator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endogenous repair factor production accelerator will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4079886